QUANTUM GENOMICS overview

Press Release Paris, April 30, 2025, 6:00 PM Quantum Genomics publishes its 2024 annual financial statements and announces a change in listing sponsor Availability of the 2024 annual financial report New listing sponsor agreement with EuroLand Corporate Update on the suspension of the Company's share listing Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC) (the “Company”) today announces its 2024 financial results, approved by the Board of Directors on April 29, 2025, and provides...

Quantum Genomics provides an update on its situation Trading suspension of the shares of the Company decided by Euronext since October 25 th , 2024 Search for a suitable reverse take over partner initiated in December 2024 and still on going Uncertainty over the ability to find a new business partner Yearly accounts 2024 expected to b released by April 30 th , 2025 Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC) (the “Company”) provides an update on its operational situation...

Press Realse Paris, 09 :04/2024, 18h 00 Quantum Genomics reviewed its financial situation and announced that it has filed a declaration of cessation of payment today Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC) provides an update on its financial situation and announces that it has today filed a declaration of cessation of payments with the Paris Commercial Court. As a reminder, following the failure of the REFRESH Phase III trial on firibastat in October 2022, Quantum Genomics...

The Quantum Genomics Company (Euronext Growth - FR0011648971 - ALQGC) announces that, as part of its merger project with Exactcure, French HealthTech developing artificial intelligence software to adapt medication intake to the profile of each individual, the transactions concerning the reduction of its share capital and the contribution of 100% of ExactCure's shares were approved by the Shareholders at the General Meeting held on 24 April 2024. The Joint General Meeting of Shareholders of...

Press Release Paris, March 13, 2024, 6 PM Quantum Genomics publishes its results for the 2023 financial year. The merger with ExactCure, which marks the strategic redeployment of the company and will be submiCed for a shareholder vote on April 24. Quantum Genomics (Euronext Growth—FR0011648971 - ALQGC) publishes its financial results for the 2023 financial year today. The Board of Directors approved the annual accounts, which met on March 12, 2024. The audit procedures have been carried out,...